Efficacy and safety of pralsetinib in patients with advanced RET fusion-positive non-small cell lung cancer.
Zhou Q, Zhao J, Chang J, Wang H, Fan Y, Wang K, Wu G, Nian W, Sun Y, Sun M, Wang X, Shi H, Zheng X, Yao S, Qin M, Shen Z, Yang J, Wu YL.
Zhou Q, et al. Among authors: wang h, wang x, wang k.
Cancer. 2023 Oct 15;129(20):3239-3251. doi: 10.1002/cncr.34897. Epub 2023 Jun 6.
Cancer. 2023.
PMID: 37282666
Free article.